tm logo
AC AQUACELLE
Live/Registered
REGISTERED

on 15 Nov 2022

Last Applicant/ Owned by

Frenchs Forest NSW 2086

AU

Serial Number

79314441 filed on 23rd Apr 2021

Registration Number

6897520 registered on 15th Nov 2022

in the Principal Register

Correspondent Address

Jennifer A. Visintine

Jennifer A. Visintine

One US Bank Plaza

St. Louis, MO 63101

Filing Basis

No Filing Basis

Disclaimer

NO DATA

AC AQUACELLE

Pharmaceutical products, namely, drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals all in the nature of pharmaceutical preparation for use as an ingredient in Self Micro-Emulsifying Drug Delivery System (SMEDDS) for nutraceutical, cosmeceutical, and veterinary applications comprising tablets, gels, creams, oral suspension, irrigation solution, Read More

Classification Information


Class [005]
Pharmaceutical Products


Pharmaceutical products, namely, drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals all in the nature of pharmaceutical preparation for use as an ingredient in Self Micro-Emulsifying Drug Delivery System (SMEDDS) for nutraceutical, cosmeceutical, and veterinary applications comprising tablets, gels, creams, oral suspension, irrigation solution, beverages, capsules, powdered preparations, liquid solutions and liquid preparations that increases the oral bioavailability and absorption of lipophilic active ingredients, namely, vitamin D, vitamin E, vitamin A, vitamin K, omega-3s and co-enzyme Q10, for the continuous release of a wide variety of therapeutic agents; nutritional preparations for medical use, namely, medications used for the delivery and absorption of nutrients being pharmaceutical products for use as an ingredient in Self Micro-Emulsifying Drug Delivery System (SMEDDS) for nutraceutical, cosmeceutical, and veterinary applications comprising tablets, gels, creams, oral suspension, irrigation solution, beverages, capsules, powdered preparations, liquid solutions and liquid preparations that increases the oral bioavailability and absorption of lipophilic active ingredients, namely, vitamin D, vitamin E, vitamin A, vitamin K, omega-3s and co-enzyme Q10, for the continuous release of a wide variety of therapeutic agents; chemical products for use in medical or veterinary biotechnology, namely, chemical preparations for increasing bioavailability and absorption of active ingredients in foodstuffs and medicines, being pharmaceutical products for use as an ingredient in Self Micro-Emulsifying Drug Delivery System (SMEDDS) for comprising tablets, gels, creams, oral suspension, irrigation solution, beverages, capsules, powdered preparations, liquid solutions and liquid preparations that increases the oral bioavailability and absorption of lipophilic active ingredients, namely, vitamin D, vitamin E, vitamin A, vitamin K, omega-3s and co-enzyme Q10, for the continuous release of a wide variety of therapeutic agents; medicated food additives being pharmaceutical products that facilitate or increase the absorption of vitamins and minerals, namely, pharmaceutical products for use as an ingredient in Self Micro-Emulsifying Drug Delivery System (SMEDDS) for nutraceutical, cosmeceutical, and veterinary applications comprising tablets, gels, creams, oral suspension, beverages, capsules, powdered preparations, liquid solutions and liquid preparations that increases the oral bioavailability and absorption of lipophilic active ingredients, namely, vitamin D, vitamin E, vitamin A, vitamin K, omega-3s and co-enzyme Q10, for the continuous release of a wide variety of therapeutic agents

Mark Details


Serial Number

No 79314441

Mark Type

No Service/Collective Mark

Attorney Docket Number

No 69016-220375

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
29th Mar 2023FINAL DECISION TRANSACTION PROCESSED BY IB
08th Mar 2023FINAL DISPOSITION NOTICE SENT TO IB
08th Mar 2023FINAL DISPOSITION PROCESSED
15th Feb 2023FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
15th Nov 2022NOTICE OF REGISTRATION CONFIRMATION EMAILED
15th Nov 2022REGISTERED-PRINCIPAL REGISTER
17th Sep 2022NEW REPRESENTATIVE AT IB RECEIVED
30th Aug 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
30th Aug 2022PUBLISHED FOR OPPOSITION
10th Aug 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED